PTCD1 Is Required for Mitochondrial Oxidative-Phosphorylation: Possible Genetic Association with Alzheimer's Disease

In addition to amyloid-β plaques and tau tangles, mitochondrial dysfunction is implicated in the pathology of Alzheimer's disease (AD). Neurons heavily rely on mitochondrial function, and deficits in brain energy metabolism are detected early in AD; however, direct human genetic evidence for mitochondrial involvement in AD pathogenesis is limited. We analyzed whole-exome sequencing data of 4549 AD cases and 3332 age-matched controls and discovered that rare protein altering variants in the gene pentatricopeptide repeat-containing protein 1 (PTCD1) show a trend for enrichment in cases compared with controls. We show here that PTCD1 is required for normal mitochondrial rRNA levels, proper assembly of the mitochondrial ribosome and hence for mitochondrial translation and assembly of the electron transport chain. Loss of PTCD1 function impairs oxidative phosphorylation and forces cells to rely on glycolysis for energy production. Cells expressing the AD-linked variant of PTCD1 fail to sustain energy production under increased metabolic stress. In neurons, reduced PTCD1 expression leads to lower ATP levels and impacts spontaneous synaptic activity. Thus, our study uncovers a possible link between a protein required for mitochondrial function and energy metabolism and AD risk. SIGNIFICANCE STATEMENT Mitochondria are the main source of cellular energy and mitochondrial dysfunction is implicated in the pathology of Alzheimer's disease (AD) and other neurodegenerative disorders. Here, we identify a variant in the gene PTCD1 that is enriched in AD patients and demonstrate that PTCD1 is required for ATP generation through oxidative phosphorylation. PTCD1 regulates the level of 16S rRNA, the backbone of the mitoribosome, and is essential for mitochondrial translation and assembly of the electron transport chain. Cells expressing the AD-associated variant fail to maintain adequate ATP production during metabolic stress, and reduced PTCD1 activity disrupts neuronal energy homeostasis and dampens spontaneous transmission. Our work provides a mechanistic link between a protein required for mitochondrial function and genetic AD risk.

[1]  Robert A Wright,et al.  Developing a Suite of Online Learning Modules on the Components of Next-Generation Sequencing Projects , 2020, Medical reference services quarterly.

[2]  J. Pa,et al.  Mitochondria and Alzheimer’s: Is PTCD1 the Smoking Gun? , 2019, Trends in Neurosciences.

[3]  D. Mochly‐Rosen,et al.  Mortal engines: Mitochondrial bioenergetics and dysfunction in neurodegenerative diseases. , 2018, Pharmacological research.

[4]  M. Colonna,et al.  TREM2 — a key player in microglial biology and Alzheimer disease , 2018, Nature Reviews Neurology.

[5]  M. Colonna,et al.  TREM2-Dependent Effects on Microglia in Alzheimer’s Disease , 2018, Front. Aging Neurosci..

[6]  M. Pérez,et al.  Contribution of Tau Pathology to Mitochondrial Impairment in Neurodegeneration , 2018, Front. Neurosci..

[7]  Stefan J. Siira,et al.  PTCD1 Is Required for 16S rRNA Maturation Complex Stability and Mitochondrial Ribosome Assembly. , 2018, Cell reports.

[8]  Michael J. Devine,et al.  Mitochondria at the neuronal presynapse in health and disease , 2018, Nature Reviews Neuroscience.

[9]  M. Mattson,et al.  Intermittent metabolic switching, neuroplasticity and brain health , 2018, Nature Reviews Neuroscience.

[10]  Yuri Zilberter,et al.  The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction , 2017, Journal of neuroscience research.

[11]  Bryan J. Neth,et al.  Insulin Resistance and Alzheimer’s Disease: Bioenergetic Linkages , 2017, Front. Aging Neurosci..

[12]  V. Ramakrishnan,et al.  Structures of the human mitochondrial ribosome in native states of assembly , 2017, Nature Structural &Molecular Biology.

[13]  Maxim N. Artyomov,et al.  TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease , 2017, Cell.

[14]  Victoria P. A. Johnstone,et al.  Adult-onset obesity is triggered by impaired mitochondrial gene expression , 2017, Science Advances.

[15]  Nick C Fox,et al.  Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease , 2017, Nature Genetics.

[16]  David V. Hansen,et al.  TREM2, Microglia, and Neurodegenerative Diseases. , 2017, Trends in molecular medicine.

[17]  M. Z. Cader,et al.  Mitophagy and Alzheimer’s Disease: Cellular and Molecular Mechanisms , 2017, Trends in Neurosciences.

[18]  Anushya Muruganujan,et al.  PANTHER version 11: expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements , 2016, Nucleic Acids Res..

[19]  B. Albensi,et al.  Mechanisms of Mitochondrial Dysfunction in Alzheimer’s Disease , 2015, Molecular Neurobiology.

[20]  R. Youle,et al.  The Mitochondrial Basis of Aging. , 2016, Molecular cell.

[21]  J. Dennis,et al.  Mitochondrial Dysfunction in Alzheimer’s Disease and the Rationale for Bioenergetics Based Therapies , 2016, Aging and disease.

[22]  Eric Karran,et al.  The Cellular Phase of Alzheimer’s Disease , 2016, Cell.

[23]  Melanie A. Huntley,et al.  Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic Antibodies , 2016, Neuron.

[24]  M. Mancuso,et al.  Alzheimer's Pathogenesis and Its Link to the Mitochondrion , 2015, Oxidative medicine and cellular longevity.

[25]  M. Barbagallo,et al.  Type 2 diabetes mellitus and Alzheimer's disease. , 2014, World journal of diabetes.

[26]  D. A. Clayton,et al.  Isolation of mitochondria from cells and tissues. , 2014, Cold Spring Harbor protocols.

[27]  D. A. Clayton,et al.  Purification of mitochondria by sucrose step density gradient centrifugation. , 2014, Cold Spring Harbor protocols.

[28]  T. Maniatis,et al.  An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex , 2014, The Journal of Neuroscience.

[29]  M. Minczuk,et al.  MRM2 and MRM3 are involved in biogenesis of the large subunit of the mitochondrial ribosome , 2014, Molecular biology of the cell.

[30]  Brendan MacLean,et al.  MSstats: an R package for statistical analysis of quantitative mass spectrometry-based proteomic experiments , 2014, Bioinform..

[31]  Teng Jiang,et al.  Microglia in Alzheimer's Disease , 2014, BioMed research international.

[32]  N. Larsson,et al.  Making proteins in the powerhouse. , 2014, Cell metabolism.

[33]  R. Swerdlow,et al.  The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives. , 2014, Biochimica et biophysica acta.

[34]  Beril Talim,et al.  Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies. , 2014, JAMA.

[35]  J. Nunnari,et al.  Mitochondrial form and function , 2014, Nature.

[36]  Mauricio O. Carneiro,et al.  From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline , 2013, Current protocols in bioinformatics.

[37]  Marie Kelly-Worden,et al.  Mitochondrial Dysfunction and Alzheimer’s Disease , 2013 .

[38]  K. Takeyasu,et al.  Human G-proteins, ObgH1 and Mtg1, associate with the large mitochondrial ribosome subunit and are involved in translation and assembly of respiratory complexes , 2013, Nucleic acids research.

[39]  E. Shoubridge,et al.  The conserved interaction of C7orf30 with MRPL14 promotes biogenesis of the mitochondrial large ribosomal subunit and mitochondrial translation , 2013, Molecular biology of the cell.

[40]  J. Smeitink,et al.  OXPHOS mutations and neurodegeneration , 2012, The EMBO journal.

[41]  M. Beal,et al.  Mitochondrial Dysfunction in Neurodegenerative Diseases , 2012, Journal of Pharmacology and Experimental Therapeutics.

[42]  T. Mercer,et al.  The human mitochondrial transcriptome and the RNA‐binding proteins that regulate its expression , 2012, Wiley interdisciplinary reviews. RNA.

[43]  O. Rackham,et al.  The role of mammalian PPR domain proteins in the regulation of mitochondrial gene expression. , 2012, Biochimica et biophysica acta.

[44]  Ole A. Andreassen,et al.  A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline , 2012, Nature.

[45]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[46]  Pablo Cingolani,et al.  © 2012 Landes Bioscience. Do not distribute. , 2022 .

[47]  M. Huynen,et al.  C7orf30 specifically associates with the large subunit of the mitochondrial ribosome and is involved in translation , 2012, Nucleic acids research.

[48]  R. McPherson,et al.  Galactose Enhances Oxidative Metabolism and Reveals Mitochondrial Dysfunction in Human Primary Muscle Cells , 2011, PloS one.

[49]  Pierre J Magistretti,et al.  Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. , 2011, Cell metabolism.

[50]  J. Mattick,et al.  RNA processing in human mitochondria , 2011, Cell cycle.

[51]  David M Holtzman,et al.  Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease. , 2011, Archives of neurology.

[52]  P. Stepien,et al.  Involvement of human ELAC2 gene product in 3' end processing of mitochondrial tRNAs , 2011, RNA biology.

[53]  B. Habermann,et al.  MTERF4 regulates translation by targeting the methyltransferase NSUN4 to the mammalian mitochondrial ribosome. , 2011, Cell metabolism.

[54]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[55]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[56]  Dimitrios Kapogiannis,et al.  Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease , 2011, The Lancet Neurology.

[57]  R. Mahley,et al.  Apolipoprotein E4 Domain Interaction Mediates Detrimental Effects on Mitochondria and Is a Potential Therapeutic Target for Alzheimer Disease* , 2010, The Journal of Biological Chemistry.

[58]  Eva L. Feldman,et al.  How does diabetes accelerate Alzheimer disease pathology? , 2010, Nature Reviews Neurology.

[59]  I. Ferreira,et al.  Multiple Defects in Energy Metabolism in Alzheimers Disease , 2010 .

[60]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[61]  Robert W. Taylor,et al.  Mitochondrial DNA mutations and human disease. , 2010, Biochimica et biophysica acta.

[62]  D. Butterfield,et al.  Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease. , 2010, Antioxidants & redox signaling.

[63]  M. D. de Leon,et al.  Maternal transmission of Alzheimer's disease: Prodromal metabolic phenotype and the search for genes , 2010, Human Genomics.

[64]  A D Roses,et al.  A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease , 2009, The Pharmacogenomics Journal.

[65]  Xiaomin Song,et al.  Amyloid-β and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice , 2009, Proceedings of the National Academy of Sciences.

[66]  J. Whelan,et al.  Pentatricopeptide repeat domain protein 1 lowers the levels of mitochondrial leucine tRNAs in cells , 2009, Nucleic acids research.

[67]  George Perry,et al.  Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease , 2009, The Journal of Neuroscience.

[68]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[69]  L. Margaritis,et al.  Intracellular Clusterin Inhibits Mitochondrial Apoptosis by Suppressing p53-Activating Stress Signals and Stabilizing the Cytosolic Ku70-Bax Protein Complex , 2009, Clinical Cancer Research.

[70]  M. Mattson,et al.  Mitochondria in Neuroplasticity and Neurological Disorders , 2008, Neuron.

[71]  Alberto Pupi,et al.  Brain Glucose Hypometabolism and Oxidative Stress in Preclinical Alzheimer's Disease , 2008, Annals of the New York Academy of Sciences.

[72]  M. Mann,et al.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.

[73]  Winnie S. Liang,et al.  Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons , 2008, Proceedings of the National Academy of Sciences.

[74]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[75]  Yvonne Will,et al.  Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[76]  M. Beal,et al.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.

[77]  D. Galati,et al.  Accumulation of Amyloid Precursor Protein in the Mitochondrial Import Channels of Human Alzheimer’s Disease Brain Is Associated with Mitochondrial Dysfunction , 2006, The Journal of Neuroscience.

[78]  W. Markesbery,et al.  Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease , 2006, Neurobiology of Aging.

[79]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[80]  R. Mahley,et al.  Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[81]  X. Chen,et al.  Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease , 2005 .

[82]  R. Taichman,et al.  Clusterin inhibits apoptosis by interacting with activated Bax , 2005, Nature Cell Biology.

[83]  R. Ravid,et al.  Proteomic and Functional Analyses Reveal a Mitochondrial Dysfunction in P301L Tau Transgenic Mice* , 2005, Journal of Biological Chemistry.

[84]  Xi Chen,et al.  Materials and Methods Som Text Figs. S1 and S2 Table S1 References Abad Directly Links A␤ to Mitochondrial Toxicity in Alzheimer's Disease , 2022 .

[85]  S. Ackerman,et al.  MTG1 codes for a conserved protein required for mitochondrial translation. , 2003, Molecular biology of the cell.

[86]  R. Malinow,et al.  APP Processing and Synaptic Function , 2003, Neuron.

[87]  A. Nunomura,et al.  Oxidative Damage Is the Earliest Event in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.

[88]  A. Nunomura,et al.  Mitochondrial abnormalities in Alzheimer disease , 2000, Neurobiology of Aging.

[89]  M. D. de Leon,et al.  Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[90]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup , 2011 .

[91]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[92]  V. Mootha,et al.  The mitochondrial proteome and human disease. , 2010, Annual review of genomics and human genetics.

[93]  George Perry,et al.  Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology. , 2010, Biochimica et biophysica acta.

[94]  I. Ferreira,et al.  Multiple defects in energy metabolism in Alzheimer's disease. , 2010, Current drug targets.

[95]  A. Reichert,et al.  Cristae formation-linking ultrastructure and function of mitochondria. , 2009, Biochimica et biophysica acta.

[96]  D. Blacker,et al.  Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.